Use of Medical Therapy and Success of Laser Surgery and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia

Urology

Volumn 86, Issue 6, 2015, Pages 1115-1122

  Strope, Seth A ^a   Vetter, Joel ^a   Elliott, Sean ^b   Andriole, Gerald L ^a   Olsen, Margaret A ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; SPASMOLYTIC AGENT; STEROID 5ALPHA REDUCTASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; DRUG USE; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REPEAT PROCEDURE; RETREATMENT; TRANSURETHRAL RESECTION; COMPLICATION; LOW LEVEL LASER THERAPY; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCRIPTION; PROSTATIC HYPERPLASIA; PROSTATISM; REOPERATION; STATISTICS AND NUMERICAL DATA;

5-ALPHA REDUCTASE INHIBITORS; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; DRUG PRESCRIPTIONS; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; PARASYMPATHOLYTICS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSTATIC HYPERPLASIA; PROSTATISM; REOPERATION; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 84955505778     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2015.07.019     Document Type: Article

References (19)

1. X. Yu, S.P. Elliott, T.J. Wilt, and A.M. McBean Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies J Urol 180 2008 241 245 discussion: 245
2. A.E. Te, T.R. Malloy, B.S. Stein, and et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial J Urol 172 2004 1404 1408
3. S.A. Ahyai, P. Gilling, S.A. Kaplan, and et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement Eur Urol 58 2010 384 397
4. A. Bachmann, A. Tubaro, N. Barber, and et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial-the GOLIATH study Eur Urol 65 2014 931 942
5. J.N. Cornu, S. Ahyai, A. Bachmann, and et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update Eur Urol 67 2015 1066 1096
6. R.M. Kuntz, K. Lehrich, and S.A. Ahyai Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial Eur Urol 53 2008 160 166
7. A. Al-Ansari, N. Younes, V.P. Sampige, and et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up Eur Urol 58 2010 349 355
8. C. Capitan, C. Blazquez, M.D. Martin, and et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up Eur Urol 60 2011 734 739
9. S.P. Elliott, X. Yu, S.A. Strope, and A.M. McBean Comparative effectiveness of surgical therapies for benign prostatic hyperplasia J Urol 187 2012 e28 e29
10. S.A. Strope, L. Yang, K.G. Nepple, and et al. Population based comparative effectiveness of transurethral resection of the prostate and laser therapy for benign prostatic hyperplasia J Urol 187 2012 1341 1345
11. C.N. Klabunde, J.M. Legler, J.L. Warren, and et al. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients Ann Epidemiol 17 2007 584 590
12. J.D. McConnell, C.G. Roehrborn, O.M. Bautista, and et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387 2398
13. B.S. Malaeb, X. Yu, A.M. McBean, and S.P. Elliott National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008) Urology 79 2012 1111 1116
14. A. Kumar, P. Vasudeva, N. Kumar, and et al. A prospective randomized comparative study of monopolar and bipolar transurethral resection of the prostate and photoselective vaporization of the prostate in patients who present with benign prostatic obstruction: a single center experience J Endourol 27 2013 1245 1253
15. R. Autorino, R. Damiano, G. Di Lorenzo, and et al. Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate Eur Urol 55 2009 922 929
16. F. Montorsi, R. Naspro, A. Salonia, and et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia J Urol 172 2004 1926 1929
17. H.H. Han, W.J. Ko, T.K. Yoo, and et al. Factors associated with continuing medical therapy after transurethral resection of prostate Urology 84 2014 675 680
18. K.T. McVary, C.G. Roehrborn, A.L. Avins, and et al. Update on AUA guideline on the management of benign prostatic hyperplasia J Urol 185 2011 1793 1803
19. S.A. Strope, J.T. Wei, A. Smith, and et al. Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery Urology 80 2012 84 89